TB Alliance Launches First Clinical Trial of a Novel TB Drug Regimen
· First clinical trial to test multiple new TB drugs in combination · Potential for one TB drug regimen to
News
Press Releases
News
FDA awards nearly $3 million for TB research
The U.S. Food and Drug Administration today announced the award of $2.9 million to support six research projects that will
News
New Potential TB Drugs to be Investigated Against Multiple Neglected Diseases
[New York, United States and Geneva, Switzerland, July 7, 2010] The Global Alliance for TB Drug Development (TB Alliance) and
News
Lancet Article Highlights Hope in the Tuberculosis Drug Development Pipeline
According to a paper published today in The Lancet, there is unprecedented progress in the development of the global tuberculosis
News
TB Alliance and AstraZeneca Form Research Collaboration to Fight Tuberculosis
New York and Bangalore, India, May 3, 2010 – The Global Alliance for TB Drug Development (TB Alliance) and AstraZeneca
News
TB Alliance Appoints Robert C. Lorette Senior Vice President, Business Development
Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership (PDP) accelerating the discovery and development of
News
TB Alliance Appoints Dr. Carlos Morel to Board of Directors
The Global Alliance for TB Drug Development (TB Alliance) today announced the appointment of Dr. Carlos Morel to its Board
News
TB Alliance Appoints Dr. Carl Mendel Senior Vice President, Research and Development
New York, NY– January 11, 2010 The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership
News
TB Alliance Appoints Head of External Affairs
The TB Alliance recently announced the appointment of Marshall Burke, Ph.D. as the organization’s Senior Vice President, External Affairs. Dr.
News
Riminophenazine Project Reaches a Key Milestone
The Institute of Materia Medica (IMM), a member of the Chinese Academy of Sciences, was recently awarded a grant from